DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nuvigil (Armodafinil) - Published Studies

 
 



Nuvigil Related Published Studies

Well-designed clinical trials related to Nuvigil (Armodafinil)

Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study. [2014]

Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships. [2012]

The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial. [2011.08]

Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial. [2011.07]

Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C. [2011.02]

Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial. [2011]

Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. [2010.11]

Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. [2010.11]

Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. [2010.10]

Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. [2010.08.24]

Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. [2010.07.27]

A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. [2010.07]

A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. [2010.01]

A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. [2010]

A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. [2010]

Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. [2009.11]

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. [2007.03]

Well-designed clinical trials possibly related to Nuvigil (Armodafinil)

Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. [2013]

Effect of pharmacological enhancement on the cognitive and clinical psychomotor performance of sleep-deprived doctors: a randomized controlled trial. [2012]

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia. [2012]

Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. [2011.11]

Effect of Pharmacological Enhancement on the Cognitive and Clinical Psychomotor Performance of Sleep-Deprived Doctors: A Randomized Controlled Trial. [2011.10.12]

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. [2011.10]

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia. [2011.09.24]

Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. [2011.08]

Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers. [2011.06]

Modafinil modulation of the default mode network. [2011.05]

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. [2011.04]

Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. [2011.04]

Effects of modafinil on emotional processing in first episode psychosis. [2011.03.01]

The safety of modafinil in combination with oral 9-tetrahydrocannabinol in humans. [2011.03]

A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. [2011.01]

Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. [2011]

The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. [2010.12]

Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers. [2010.12]

Effects of acute modafinil on cognition in trichotillomania. [2010.12]

Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury. [2010.11.16]

Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers. [2010.11]

Modafinil reverses hypoexcitability of the motor cortex in narcoleptic patients: a TMS study. [2010.10]

Modafinil reduces microsleep during partial sleep deprivation in depressed patients. [2010.10]

Sleep restriction for 1 week reduces insulin sensitivity in healthy men. [2010.09]

Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. [2010.08.01]

Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. [2010.08]

A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. [2010.07.15]

Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. [2010.07]

Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. [2010.06.01]

Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study. [2010.06]

Modafinil for the treatment of multiple sclerosis-related fatigue. [2010.06]

Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study. [2010.06]

Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study. [2010.06]

A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence. [2010.05]

Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial. [2010.04.15]

Working memory fMRI activation in cocaine-dependent subjects: association with treatment response. [2010.03.30]

Normalizing effects of modafinil on sleep in chronic cocaine users. [2010.03]

Modafinil for Parkinson's disease fatigue. [2010.03]

Efficacy of psychostimulant drugs for cocaine dependence. [2010.02.17]

Modafinil reduces patient-reported tiredness after sedation/analgesia but does not improve patient psychomotor skills. [2010.02]

Modafinil does not serve as a reinforcer in cocaine abusers. [2010.01.15]

Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. [2010.01.15]

A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing. [2010.01]

A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. [2010]

Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study. [2010]

Modafinil reduces microsleep during partial sleep deprivation in depressed patients. [2010]

Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial. [2010]

Modafinil for Parkinson's disease fatigue. [2010]

Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. [2010]

Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment. [2009.12.15]

Modafinil and zolpidem use by emergency medicine residents. [2009.12]

Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. [2009.12]

Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. [2009.12]

Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study. [2009.11]

The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men. [2009.09.02]

Modafinil for the treatment of cocaine dependence. [2009.09.01]

Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA). [2009.09]

A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. [2009.08.15]

Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. [2009.08]

Modafinil as a potential motion sickness countermeasure. [2009.08]

Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. [2009.08]

The effect of modafinil on cognitive function in breast cancer survivors. [2009.06.15]

An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects. [2009.04.01]

Efficacy and safety of modafinil in the treatment of cancer-related fatigue. [2009.04]

Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. [2009.03]

Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep. [2009.03]

Effects of psychostimulants on alertness and spatial bias in healthy participants. [2009.03]

Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. [2009.02.01]

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. [2009.02]

Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. [2009.02]

Modafinil improves rapid shifts of attention. [2009.01]

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review. [2009.01]

Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. [2008.12.12]

Effects of modafinil on simulator driving and self-assessment of driving following sleep deprivation. [2008.12]

A placebo-controlled trial of modafinil for nicotine dependence. [2008.11.01]

Effects of modafinil and sleep loss on physiological parameters. [2008.11]

The effect of modafinil following acute CPAP withdrawal: a preliminary study. [2008.11]

Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. [2008.09]

Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. [2008.09]

Pharmacokinetics and tolerability of modafinil tablets in Chinese subjects. [2008.08]

Impact of modafinil on spasticity reduction and quality of life in children with CP. [2008.07]

The effects of modafinil on mood and cognition in Huntington's disease. [2008.07]

An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. [2008.04]

Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study. [2008.03]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017